SkyAI (SKYA)
Market Price (8/6/2026): $1.27 | Market Cap: $92.2 MilSector: Information Technology | Industry: Systems Software
SkyAI (SKYA)
Market Price (8/6/2026): $1.27Market Cap: $92.2 MilSector: Information TechnologyIndustry: Systems Software
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13% Megatrend and thematic driversMegatrends include Artificial Intelligence, and Advanced Aviation & Space. Themes include AI Software Platforms, and Drone Technology. | Weak multi-year price returns2Y Excs Rtn is -68%, 3Y Excs Rtn is -96% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -16 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -3990% Expensive valuation multiplesP/SPrice/Sales ratio is 234x Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 27628% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -3086%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -50810% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -403% Key risksSKYA key risks include [1] heavy financial dependence on its significant Solana (SOL) digital asset treasury, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13% |
| Megatrend and thematic driversMegatrends include Artificial Intelligence, and Advanced Aviation & Space. Themes include AI Software Platforms, and Drone Technology. |
| Weak multi-year price returns2Y Excs Rtn is -68%, 3Y Excs Rtn is -96% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -16 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -3990% |
| Expensive valuation multiplesP/SPrice/Sales ratio is 234x |
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 27628% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -3086%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -50810% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -403% |
| Key risksSKYA key risks include [1] heavy financial dependence on its significant Solana (SOL) digital asset treasury, Show more. |
Qualitative Assessment
AI Analysis | Feedback
SkyAI (SKYA) stock has lost about 30% since it went public on 5/28/2026 because of the following key factors:
1. Significant Unprofitability and Early-Stage Financials Following Strategic Pivot.
SkyAI, which commenced trading under the SKYA ticker on May 28, 2026, after a strategic shift to an agentic finance platform for the Global South, reported substantial losses. The company recorded an operating loss of -$86.3 million in fiscal Q1 2026 and -$269.7 million for its fiscal year 2025 (ending December 31, 2025). This significant unprofitability, combined with relatively modest revenue of $3.33 million in fiscal Q1 2026, likely deterred investors concerned about the financial viability and execution of the new business model.
2. Rejection of Acquisition Proposal.
In June 2026, Forward Industries made an unsolicited, non-binding all-stock proposal to acquire SkyAI for an estimated $66.5 million, offering 0.367 shares of Forward common stock for each SkyAI share. This represented a premium of approximately 20% to SkyAI's closing share price of $1.29 on June 14, 2026, valuing SkyAI at $1.55 per share. SkyAI's board formed a special committee to evaluate the offer but ultimately did not respond, and Forward Industries subsequently canceled the acquisition on July 17, 2026. The rejection of a premium acquisition offer may have caused investor disappointment and led to a sell-off, as it removed a potential near-term catalyst for shareholder value realization.
Show more
SkyAI (SKYA) stock has lost about 30% since it went public on 5/28/2026 because of the following key factors:
1. Significant Unprofitability and Early-Stage Financials Following Strategic Pivot.
SkyAI, which commenced trading under the SKYA ticker on May 28, 2026, after a strategic shift to an agentic finance platform for the Global South, reported substantial losses. The company recorded an operating loss of -$86.3 million in fiscal Q1 2026 and -$269.7 million for its fiscal year 2025 (ending December 31, 2025). This significant unprofitability, combined with relatively modest revenue of $3.33 million in fiscal Q1 2026, likely deterred investors concerned about the financial viability and execution of the new business model.
2. Rejection of Acquisition Proposal.
In June 2026, Forward Industries made an unsolicited, non-binding all-stock proposal to acquire SkyAI for an estimated $66.5 million, offering 0.367 shares of Forward common stock for each SkyAI share. This represented a premium of approximately 20% to SkyAI's closing share price of $1.29 on June 14, 2026, valuing SkyAI at $1.55 per share. SkyAI's board formed a special committee to evaluate the offer but ultimately did not respond, and Forward Industries subsequently canceled the acquisition on July 17, 2026. The rejection of a premium acquisition offer may have caused investor disappointment and led to a sell-off, as it removed a potential near-term catalyst for shareholder value realization.
3. Negative Analyst Sentiment.
The market sentiment for SkyAI was further impacted by analyst coverage. As of July 28, 2026, the sole Wall Street analyst covering SKYA had issued a "Sell" rating for the stock, indicating a pessimistic outlook on its future performance. This negative analyst recommendation could have influenced investor confidence and contributed to the downward pressure on the stock price.
4. Broader AI Sector Correction and Shift to "Proof-of-Demand" Investing.
While the AI sector was a primary driver of market performance in the first half of 2026, a market pullback affecting technology and AI-related stocks began in June 2026. By late July, investors increasingly prioritized companies demonstrating tangible demand, backlog, and cash flow ("proof-of-demand") over those with aggressive spending and less clear revenue narratives. As a newly rebranded AI company with substantial operating losses and an unproven business model in a scrutinizing market, SkyAI likely suffered from this broader shift in investment criteria within the AI sector.
Show less
Stock Movement Drivers
Fundamental Drivers
nullnull
Market Drivers
4/30/2026 to 8/5/2026| Return | Correlation | |
|---|---|---|
| SKYA | ||
| Market (SPY) | 7.1% | 24.0% |
| Sector (XLK) | 16.6% | 12.7% |
Fundamental Drivers
nullnull
Market Drivers
1/31/2026 to 8/5/2026| Return | Correlation | |
|---|---|---|
| SKYA | ||
| Market (SPY) | 11.5% | 24.0% |
| Sector (XLK) | 29.4% | 12.7% |
Fundamental Drivers
nullnull
Market Drivers
7/31/2025 to 8/5/2026| Return | Correlation | |
|---|---|---|
| SKYA | ||
| Market (SPY) | 22.8% | 24.0% |
| Sector (XLK) | 42.1% | 12.7% |
Fundamental Drivers
nullnull
Market Drivers
7/31/2023 to 8/5/2026| Return | Correlation | |
|---|---|---|
| SKYA | ||
| Market (SPY) | 74.1% | 24.0% |
| Sector (XLK) | 112.4% | 12.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| SKYA Return | - | - | - | - | - | -27% | -27% |
| Peers Return | 8% | -42% | 55% | 11% | -5% | -4% | -1% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 106% |
Monthly Win Rates [3] | |||||||
| SKYA Win Rate | - | - | - | - | - | 50% | |
| Peers Win Rate | 52% | 35% | 60% | 63% | 54% | 48% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| SKYA Max Drawdown | - | - | - | - | - | - | |
| Peers Max Drawdown | -22% | -53% | -30% | -35% | -34% | -37% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: GEN, CVLT, S, PATH, EXYN.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/5/2026 (YTD)
How Low Can It Go
SKYA has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.
| Event | XLK | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -25.7% | -18.8% |
| % Gain to Breakeven | 34.5% | 23.1% |
| Time to Breakeven | 65 days | 79 days |
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -17.0% | -7.8% |
| % Gain to Breakeven | 20.4% | 8.5% |
| Time to Breakeven | 92 days | 18 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -10.0% | -9.5% |
| % Gain to Breakeven | 11.2% | 10.5% |
| Time to Breakeven | 15 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -33.1% | -24.5% |
| % Gain to Breakeven | 49.5% | 32.4% |
| Time to Breakeven | 246 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -31.2% | -33.7% |
| % Gain to Breakeven | 45.2% | 50.9% |
| Time to Breakeven | 78 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -23.8% | -19.2% |
| % Gain to Breakeven | 31.2% | 23.8% |
| Time to Breakeven | 100 days | 105 days |
In The Past
State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
SKYA has limited trading history. Below is the Information Technology sector ETF (XLK) in its place.
| Event | XLK | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -25.7% | -18.8% |
| % Gain to Breakeven | 34.5% | 23.1% |
| Time to Breakeven | 65 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -33.1% | -24.5% |
| % Gain to Breakeven | 49.5% | 32.4% |
| Time to Breakeven | 246 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -31.2% | -33.7% |
| % Gain to Breakeven | 45.2% | 50.9% |
| Time to Breakeven | 78 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -23.8% | -19.2% |
| % Gain to Breakeven | 31.2% | 23.8% |
| Time to Breakeven | 100 days | 105 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -51.5% | -53.4% |
| % Gain to Breakeven | 106.2% | 114.4% |
| Time to Breakeven | 797 days | 1085 days |
In The Past
State Street Technology Select Sector SPDR ETF's stock fell -25.7% during the 2025 US Tariff Shock. Such a loss loss requires a 34.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About SkyAI (SKYA)
SkyAI (SKYA) operates as a medical device company, specializing in the entire lifecycle of safety syringe products. Its operations encompass the research, design, development, manufacturing, distribution, and sale of these essential medical devices, primarily serving the market within the United States.
The company's flagship product is Sharps Provensa, an advanced ultra-low waste space syringe. This innovative design is specifically engineered for the efficient administration of various vaccines and a wide range of injectable medications, addressing the critical need to minimize waste in medical settings.
SkyAI's primary customers are healthcare providers, medical institutions, and public health initiatives involved in vaccination efforts and other forms of medication delivery. By providing specialized safety syringes, the company plays a role in supporting safe and efficient medical practices across the U.S. healthcare sector.
AI Analysis | Feedback
1. A specialized Becton Dickinson (BD) focusing on innovative safety syringes.
2. Like a niche medical device company, similar to a focused division of a larger healthcare firm like Johnson & Johnson, but dedicated to advanced safety syringe technology.
AI Analysis | Feedback
- Safety syringe products: These are medical devices designed to prevent needlestick injuries and ensure safe handling of needles.
- Sharps Provensa: An ultra-low waste space syringe specifically designed for the administration of various vaccines and injectable medications, aiming to minimize medication waste.
AI Analysis | Feedback
- Nephros, Inc. (Symbol: NEPH): A publicly traded medical device company that serves as an exclusive distributor for Sharps Technology's products in the United States and Canada. As a distributor, Nephros, Inc. acts as a significant direct customer.
- Other medical device distributors
- Healthcare providers such as hospitals, clinics, and pharmacies
- Pharmaceutical companies and vaccine manufacturers
- Government agencies for public health programs
AI Analysis | Feedback
- Nephron Pharmaceuticals Corporation
AI Analysis | Feedback
Paul K. Danner, Principal Executive Officer & Board Member
Mr. Danner is a seasoned public company leader with over three decades of executive experience. He has served as chief executive of four Nasdaq-listed enterprises, where he successfully executed initial public offerings, led M&A-driven growth strategies, and raised significant capital. He also held senior board leadership roles across six different public companies. Before his role at Sharps Technology (now SkyAI), Mr. Danner was chief financial and administrative officer of PAY2DAY Solutions, Inc. dba Authvia since 2013 and served as chief executive officer of Alliance MMA, Inc. from 2016 to 2018. He is also a retired U.S. Navy Captain.
Arthur Levine, Interim Chief Financial Officer
Mr. Levine was appointed as interim Chief Financial Officer for SkyAI (formerly Sharps Technology) in February 2026. He is a Certified Public Accountant and a Wharton graduate, bringing prior CFO experience from NextNRG, Inc. and Sensus Healthcare.
Alice Zhang, Chief Investment Officer & Board Member
Ms. Zhang possesses extensive experience in scaling businesses across the Global South. She co-founded Jambo Technology, a prominent Web3 mobile infrastructure that has expanded its reach to users in over 100 countries and is built on Solana.
Matthew A. Carter, Vice President of Finance & Accounting
Braden Miller, Vice President, Operations
AI Analysis | Feedback
Key Risks to SkyAI (SKYA)
The primary risks to SkyAI, Inc. (SKYA), formerly Sharps Technology Inc., stem from its recent and significant pivot from a medical device company to a business primarily focused on a digital asset treasury strategy and the development of an "Agentic Finance" platform for the Global South.
- Volatility of Digital Assets: SkyAI's financial performance and asset base are heavily dependent on the market price of Solana (SOL) and other digital assets. The company holds a significant treasury of SOL and generates substantial revenue from staking these digital assets. Fluctuations or significant declines in the value of SOL or other digital assets could materially and adversely impact the company's financial health, operating results, and overall valuation.
- Execution Risk of the Agentic Finance Strategy: SkyAI has recently rebranded and shifted its strategic focus to building an "Agentic Finance platform serving the Global South". This represents an ambitious and unproven business model in a complex and diverse market. The successful execution of this new strategy, including the development of technology, establishment of partnerships, and achieving market adoption, poses significant risks. Challenges in implementing this strategy could hinder the company's ability to generate sustainable revenue and achieve profitability from its new core business.
- Regulatory and Legal Environment for Digital Assets and Fintech: Operating with a digital asset treasury and developing an "Agentic Finance" platform, particularly in the Global South, exposes SkyAI to a dynamic and often uncertain regulatory and legal landscape. Changes in regulations pertaining to cryptocurrencies, blockchain technology, decentralized finance, and international financial services in various jurisdictions could lead to increased compliance costs, restrict business operations, or even render certain aspects of the business model untenable. The complexity and evolving nature of these regulations present a substantial risk to the company's future operations and growth.
AI Analysis | Feedback
The clear emerging threat for Sharps Technology Inc. (SKYA) is the advancement and increasing adoption of needle-free injection systems. These systems offer an alternative method for administering vaccines and injectable medications without the use of a traditional needle and syringe, potentially rendering conventional syringe products, including safety syringes, less relevant or obsolete for various applications. This technology directly addresses concerns about needle-stick injuries, patient discomfort, and could potentially offer comparable or superior waste reduction for specific drug delivery scenarios, similar to how streaming services fundamentally changed media consumption compared to physical rentals.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
Share Repurchases
- SkyAI, Inc. (formerly Sharps Technology Inc.) announced a stock repurchase program on October 2, 2025, to acquire up to $100 million of its outstanding common stock.
Share Issuance
- The number of outstanding shares significantly increased by 271,952.24% in one year, with 42.32 million shares outstanding as of a recent date (likely March 31, 2026).
- Sharps Technology Inc. announced a private placement exceeding $400 million, involving the sale of common stock and warrants, to establish its Solana digital asset treasury strategy, expected to close around August 28, 2025.
- As of May 15, 2026, certain affiliates reported beneficial ownership including pre-funded warrants exercisable for 4,234,615 shares and stapled warrants exercisable for 5,384,615 shares.
Inbound Investments
- SkyAI, Inc. (as Sharps Technology, Inc.) received $400 million in funding from a group of investors in a transaction that closed on August 28, 2025, to establish its Solana digital asset treasury strategy.
- The company also received $3.8 million in funding, with the transaction closing on February 6, 2023.
Outbound Investments
- Sharps Technology, Inc. completed the acquisition of Safegard Medical (Hungary) Kft. for $2.5 million on July 8, 2022.
Capital Expenditures
- No specific dollar value of traditional capital expenditures on property, plant, and equipment was prominently disclosed for the last 3-5 years. The company's recent strategic focus, as SkyAI, Inc., is on building an AI-driven agentic finance platform and accumulating SOL tokens as part of its digital asset treasury strategy.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 17.41 |
| Mkt Cap | 7.1 |
| Rev LTM | 1,216 |
| Op Inc LTM | 101 |
| FCF LTM | 258 |
| FCF 3Y Avg | 218 |
| CFO LTM | 265 |
| CFO 3Y Avg | 223 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 18.4% |
| Rev Chg 3Y Avg | 15.4% |
| Rev Chg Q | 19.1% |
| QoQ Delta Rev Chg LTM | 4.8% |
| Op Inc Chg LTM | 20.5% |
| Op Inc Chg 3Y Avg | 21.1% |
| Op Mgn LTM | 6.0% |
| Op Mgn 3Y Avg | 2.0% |
| QoQ Delta Op Mgn LTM | 2.5% |
| CFO/Rev LTM | 21.8% |
| CFO/Rev 3Y Avg | 22.5% |
| FCF/Rev LTM | 21.3% |
| FCF/Rev 3Y Avg | 21.8% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Medical Device Packaging | 0 | |||
| Corporate | 0 | |||
| Digital Assets | 0 | |||
| Single Segment | 0 | 0 | 0 | |
| Total | 0 | 0 | 0 | 0 |
| $ Mil | 2025 |
|---|---|
| Medical Device Packaging | -1 |
| Corporate | -15 |
| Digital Assets | -254 |
| Total | -270 |
| $ Mil | 2025 | 2024 |
|---|---|---|
| Corporate | -10 | |
| Medical Device Packaging | -13 | |
| Digital Assets | -259 | |
| Single Segment | -9 | |
| Total | -283 | -9 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Digital Assets | 257 | ||||
| Corporate | 11 | ||||
| Medical Device Packaging | 1 | ||||
| Single Segment | 7 | 12 | 12 | 6 | |
| Total | 269 | 7 | 12 | 12 | 6 |
Price Behavior
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.90 | 1.68 | -1.54 | 0.17 | 1.39 | 0.63 |
| Up Beta | 0.01 | 4.30 | -2.79 | 0.02 | -1.49 | 1.07 |
| Down Beta | 4.81 | 2.39 | 1.04 | -0.20 | -0.94 | -4.11 |
| Up Capture | 127% | -40% | -12% | -5% | -2% | -0% |
| Bmk +ve Days | 11 | 22 | 35 | 67 | 138 | 427 |
| Stock +ve Days | 10 | 16 | 17 | 17 | 17 | 17 |
| Down Capture | -141% | 159% | 137% | 71% | 47% | 26% |
| Bmk -ve Days | 11 | 21 | 28 | 59 | 114 | 326 |
| Stock -ve Days | 11 | 26 | 26 | 26 | 26 | 26 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SKYA | |
|---|---|---|---|---|
| SKYA | -27.8% | 96.4% | -1.37 | - |
| Sector ETF (XLK) | 42.5% | 25.9% | 1.33 | 12.7% |
| Equity (SPY) | 23.1% | 12.9% | 1.34 | 24.0% |
| Gold (GLD) | 25.4% | 28.3% | 0.79 | 37.6% |
| Commodities (DBC) | 29.5% | 19.8% | 1.19 | -3.2% |
| Real Estate (VNQ) | 14.4% | 13.7% | 0.74 | -10.0% |
| Bitcoin (BTCUSD) | -44.6% | 42.9% | -1.25 | 60.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SKYA | |
|---|---|---|---|---|
| SKYA | -6.3% | 96.4% | -1.37 | - |
| Sector ETF (XLK) | 20.4% | 25.8% | 0.70 | 12.7% |
| Equity (SPY) | 13.4% | 17.2% | 0.60 | 24.0% |
| Gold (GLD) | 18.2% | 18.6% | 0.79 | 37.6% |
| Commodities (DBC) | 8.1% | 19.6% | 0.31 | -3.2% |
| Real Estate (VNQ) | 2.5% | 18.9% | 0.03 | -10.0% |
| Bitcoin (BTCUSD) | 9.9% | 53.0% | 0.37 | 60.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SKYA | |
|---|---|---|---|---|
| SKYA | -3.2% | 96.4% | -1.37 | - |
| Sector ETF (XLK) | 24.6% | 24.9% | 0.89 | 12.7% |
| Equity (SPY) | 15.3% | 17.9% | 0.73 | 24.0% |
| Gold (GLD) | 12.0% | 16.2% | 0.60 | 37.6% |
| Commodities (DBC) | 7.1% | 18.0% | 0.31 | -3.2% |
| Real Estate (VNQ) | 4.9% | 20.7% | 0.20 | -10.0% |
| Bitcoin (BTCUSD) | 58.2% | 66.2% | 0.98 | 60.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/2/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 03/31/2026 | 10-K |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/13/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/27/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/14/2024 | 10-Q |
| 12/31/2023 | 03/29/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/31/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 03/31/2026 | 10-K |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/13/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/27/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/14/2024 | 10-Q |
| 12/31/2023 | 03/29/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/31/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| 03/31/2022 | 05/25/2022 | 10-Q |
| 12/31/2021 | 04/15/2022 | 424B4 |
Industry Resources
| Information Technology Resources |
| TechCrunch |
| Wired |
| CIO |
| MIT Technology Review |
| Gartner Insights |
| Ars Technica |
| Systems Software Resources |
| CNET |
| ZDNet |
| Gartner |
| Software Development Times |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.